The Hyderabad Pharma Firm, Shantha Biologics, has secured a major manufacturing agreement with Novo Nordisk, marking another milestone for India's pharmaceutical sector.
1.jpg "New DPCO Amendments Simplify Drug Launches, Cut Compliance Burden")
The government sets new regulatory rules on drug launches, that relieves the hurdles for Indian manufacturers in obtaining regulatory approvals for supply delays. This in turn, aims to improve the quick market entry of drugs and improve sales
India has introduced a major regulatory change for Stem Cell and Gene Therapy, bringing these advanced treatments under a central licensing framework.
EMA has recently approved Lupin's drug capsules that could change the care for the rare muscle disorder, non-dystrophic myotonias that is seen in one among a million people
Delhi's dengue fight received a major boost after Union Health Minister Jagat Prakash Nadda chaired a high-level meeting to review the city's preparedness against dengue ahead of the peak transmission season.
A new mRNA Vaccine Analysis has delivered reassuring findings about the safety and effectiveness of mRNA vaccines.
India may need to rethink its India drug rules before making changes that could impact the country's position as a global leader in affordable medicines.
Glenmark shares came under pressure after the US FDA issued six observations following an inspection of the company's Goa plant.
Telangana welcomes corporates by setting the ground for business and development for pharmaceuticals, GCCs, research institutions, and startups, taking a shift from implementing subsidies to being prominent in business and innovation
AI drug discovery is gaining momentum as pharmaceutical companies look for faster and more efficient ways to develop new medicines.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")